American National Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

American National Bank & Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6	Closed	-$438	–	694
2023 Q3	$438	Hold	6	–	–	﹤0.01%	550
2023 Q2	$499	Hold	6	–	–	﹤0.01%	533
2023 Q1	$457	Hold	6	–	–	﹤0.01%	531
2022 Q4	$1K	Buy	+6	New	+$486	﹤0.01%	604

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

American National Bank & Trust's XBI Position: Q4 2023 in Review

American National Bank & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 6 shares — an estimated $438 sold.

American National Bank & Trust first reported a position in XBI in Q4 2022 and held it in 4 quarters. The position peaked at $1K in Q4 2022. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

American National Bank & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
American National Bank & Trust sold 6 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $438.
American National Bank & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 4 quarters.
American National Bank & Trust's State Street SPDR S&P Biotech ETF position peaked at $1K in Q4 2022.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on American National Bank & Trust's 13F filing for Q4 2023, filed 8 Feb 2024.